Apr, 2019
Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer
Thoracic Cancer
- ,
- ,
- ,
- ,
- ,
- ,
- Volume
- 10
- Number
- 4
- First page
- 1005
- Last page
- 1008
- Language
- English
- Publishing type
- Research paper (scientific journal)